ListarDepartamento de Anatomía y Anatomía Patológica Comparadas y Toxicología por tema "PD-1"
Mostrando ítems 1-2 de 2
-
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
(MDPI, 2020)Urothelial carcinoma (UC) is a frequent cause of cancer-related deaths worldwide. Metastatic UC has been historically associated with poor prognosis, with a median overall survival of approximately 15 months and a 5-year ... -
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
(MDPI, 2021)A number of immune checkpoint inhibitors (ICIs) have been approved as first-line therapy in case of cisplatin-ineligible patients or as second-line therapy for patients with metastatic urothelial carcinoma (mUC) of the ...